Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Systemic inflammation in predicting COPD exacerbations.

Mador MJ, Sethi S.

JAMA. 2013 Jun 12;309(22):2390-1. doi: 10.1001/jama.2013.5733. No abstract available.

PMID:
23757089
2.

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.

Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG.

JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732.

PMID:
23757083
3.

[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].

Saldías PF, Díaz PO, Dreyse DJ, Gaggero BA, Sandoval AC, Lisboa BC.

Rev Med Chil. 2012 Jan;140(1):10-8. doi: /S0034-98872012000100002. Spanish.

4.

Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.

Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG.

Am J Respir Crit Care Med. 2012 Nov 15;186(10):982-8. doi: 10.1164/rccm.201206-1113OC.

PMID:
22983959
5.

[Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].

Morales S A, Dreyse D J, Díaz P O, Saldías P F, Carrasco M, Lisboa B C.

Rev Med Chil. 2010 Aug;138(8):957-64. doi: /S0034-98872010000800003. Spanish.

6.

Systemic inflammation in patients with chronic obstructive pulmonary disease: one size no longer fits all!

Burgel PR, Mannino D.

Am J Respir Crit Care Med. 2012 Nov 15;186(10):936-7. doi: 10.1164/rccm.201209-1634ED. No abstract available.

PMID:
23155208
7.

Increased systemic inflammation is a risk factor for COPD exacerbations.

Groenewegen KH, Postma DS, Hop WC, Wielders PL, Schlösser NJ, Wouters EF; COSMIC Study Group..

Chest. 2008 Feb;133(2):350-7. doi: 10.1378/chest.07-1342.

PMID:
18198263
8.

[C-Reactive protein levels in patients with chronic obstructive pulmonary disease].

Díaz O, Parada A, Ramos C, Klaassen J, Díaz JC, Andresen M, Lisboa C, Saldías F.

Rev Med Chil. 2012 May;140(5):569-78. doi: 10.4067/S0034-98872012000500003. Spanish.

9.

Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.

Gatta D, Aliprandi G, Pini L, Zanardini A, Fredi M, Tantucci C.

Eur Rev Med Pharmacol Sci. 2011 Sep;15(9):1068-73.

PMID:
22013730
10.
11.

Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease.

Biljak VR, Pancirov D, Cepelak I, Popović-Grle S, Stjepanović G, Grubišić TŽ.

Platelets. 2011;22(6):466-70. doi: 10.3109/09537104.2011.573887.

PMID:
21506665
12.

Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.

Barouchos N, Papazafiropoulou A, Iacovidou N, Vrachnis N, Barouchos N, Armeniakou E, Dionyssopoulou V, Mathioudakis AG, Christopoulou E, Koltsida S, Bassiakou E.

Scand J Clin Lab Invest. 2015 Apr;75(2):126-32. doi: 10.3109/00365513.2014.992944.

PMID:
25598350
13.

Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.

Gumus A, Altintas N, Cinarka H, Kirbas A, Hazıroglu M, Karatas M, Sahin U.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 13;10:357-65. doi: 10.2147/COPD.S77654.

14.

The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.

Karadag F, Kirdar S, Karul AB, Ceylan E.

Eur J Intern Med. 2008 Mar;19(2):104-8. doi: 10.1016/j.ejim.2007.04.026.

PMID:
18249305
15.

Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.

MacNee W.

Ann Med. 2013 May;45(3):291-300. doi: 10.3109/07853890.2012.732703. Review.

PMID:
23110517
17.

Low erythropoietin plasma levels during exacerbations of COPD.

Sala E, Balaguer C, Villena C, Ríos A, Noguera A, Núñez B, Agustí A.

Respiration. 2010;80(3):190-7. doi: 10.1159/000264604.

PMID:
19955699
18.

Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.

Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H.

Lung. 2008 Nov-Dec;186(6):403-9. doi: 10.1007/s00408-008-9106-6.

PMID:
18807087
19.

[C-reactive protein levels in patients with chronic obstructive pulmonary disease and asthma].

Urboniene D, Sakalauskas R, Sitkauskiene B.

Medicina (Kaunas). 2008;44(11):833-40. Lithuanian.

20.

The Evaluation of Serum Pentraxin-3 and High-Sensitivity C-Reactive Protein Levels in Patients with Acute Attack of COPD.

Duran L, Unsal M, Yardan T, Kati C, Bedir A, Turkeli S, Ekiz M.

Clin Lab. 2015;61(12):1911-6.

PMID:
26882815

Supplemental Content

Support Center